Want to join the conversation?
$ACET said that its subsidiary, Rising Pharmaceuticals, is launching an FDA-approved generic version of $GSK's Avodart (Dutasteride) Softgel Capsules 0.5 mg in the U.S. market. According to IMS Health, U.S. market for Dutasteride, which is used for the treatment of symptomatic BPH in men with enlarged prostate, is about $452MM.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.